Page last updated: 2024-09-04

l 738167 and Coronary Disease

l 738167 has been researched along with Coronary Disease in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Askew, BC; Cook, JJ; Glass, JD; Gould, RJ; Hand, EL; Hartman, GD; Holahan, MA; Lynch, JJ; Sitko, GR; Stump, GL; Stupienski, RF; Wallace, AA	1

Other Studies

1 other study(ies) available for l 738167 and Coronary Disease

Article	Year
Nonpeptide glycoprotein IIb/IIIa inhibitors: 14: oral antithrombotic efficacy of L-738,167 in a conscious canine model of coronary artery electrolytic injury. Circulation, 1997, Aug-05, Volume: 96, Issue:3 Topics: Administration, Oral; Animals; Azepines; Bleeding Time; Blood Platelets; Coronary Disease; Coronary Thrombosis; Dogs; Drug Administration Schedule; Female; Fibrinolytic Agents; Male; Platelet Function Tests; Platelet Glycoprotein GPIIb-IIIa Complex; Sulfonamides	1997

Article

Year

Nonpeptide glycoprotein IIb/IIIa inhibitors: 14: oral antithrombotic efficacy of L-738,167 in a conscious canine model of coronary artery electrolytic injury.

Circulation, 1997, Aug-05, Volume: 96, Issue:3

Topics: Administration, Oral; Animals; Azepines; Bleeding Time; Blood Platelets; Coronary Disease; Coronary Thrombosis; Dogs; Drug Administration Schedule; Female; Fibrinolytic Agents; Male; Platelet Function Tests; Platelet Glycoprotein GPIIb-IIIa Complex; Sulfonamides

1997